<?xml version='1.0' encoding='utf-8'?>
<document id="12099750"><sentence text="Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen."><entity charOffset="78-93" id="DDI-PubMed.12099750.s1.e0" text="corticosteroids" /><entity charOffset="95-117" id="DDI-PubMed.12099750.s1.e1" text="fluticasone propionate" /><entity charOffset="132-141" id="DDI-PubMed.12099750.s1.e2" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.12099750.s1.e0" e2="DDI-PubMed.12099750.s1.e0" /><pair ddi="false" e1="DDI-PubMed.12099750.s1.e0" e2="DDI-PubMed.12099750.s1.e1" /><pair ddi="false" e1="DDI-PubMed.12099750.s1.e0" e2="DDI-PubMed.12099750.s1.e2" /><pair ddi="false" e1="DDI-PubMed.12099750.s1.e1" e2="DDI-PubMed.12099750.s1.e1" /><pair ddi="false" e1="DDI-PubMed.12099750.s1.e1" e2="DDI-PubMed.12099750.s1.e2" /></sentence><sentence text="In HIV-infected patients, ritonavir, a potent cytochrome P450 inhibitor, is increasingly used to improve the pharmacokinetic profile of the associated protease inhibitor"><entity charOffset="26-35" id="DDI-PubMed.12099750.s2.e0" text="ritonavir" /></sentence><sentence text=" HIV physicians are often faced with potential drug-drug interaction while treating associated diseases" /><sentence text=" We report the case of an HIV-infected patient with clinical features of Cushing's syndrome due to the interaction of low dose ritonavir with inhaled fluticasone propionate (FP)"><entity charOffset="127-136" id="DDI-PubMed.12099750.s4.e0" text="ritonavir" /><entity charOffset="150-172" id="DDI-PubMed.12099750.s4.e1" text="fluticasone propionate" /><entity charOffset="174-176" id="DDI-PubMed.12099750.s4.e2" text="FP" /><pair ddi="false" e1="DDI-PubMed.12099750.s4.e0" e2="DDI-PubMed.12099750.s4.e0" /><pair ddi="false" e1="DDI-PubMed.12099750.s4.e0" e2="DDI-PubMed.12099750.s4.e1" /><pair ddi="false" e1="DDI-PubMed.12099750.s4.e0" e2="DDI-PubMed.12099750.s4.e2" /><pair ddi="false" e1="DDI-PubMed.12099750.s4.e1" e2="DDI-PubMed.12099750.s4.e1" /><pair ddi="false" e1="DDI-PubMed.12099750.s4.e1" e2="DDI-PubMed.12099750.s4.e2" /></sentence><sentence text=" Safety of life-long CYP450 inhibition has still to be demonstrated" /><sentence text="" /></document>